4,264
Total Claims
$673K
Drug Cost
698
Beneficiaries
$964
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
-9%
Cost per patient vs peers
$964 vs $1,054 avg
-1%
Brand preference vs peers
13.0% vs 13.1% avg
Brand vs Generic
87% generic
Brand: 553 claims · $583K
Generic: 3,711 claims · $90K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 186 | $220K |
| Rivaroxaban | 92 | $118K |
| Sacubitril/Valsartan | 81 | $94K |
| Empagliflozin | 67 | $73K |
| Ticagrelor | 42 | $25K |
| Evolocumab | 22 | $21K |
| Ranolazine | 63 | $9,631 |
| Atorvastatin Calcium | 495 | $8,606 |
| Metoprolol Succinate | 335 | $6,249 |
| Clopidogrel Bisulfate | 304 | $6,085 |
| Ezetimibe | 115 | $5,388 |
| Digoxin | 44 | $5,264 |
| Dofetilide | 23 | $3,995 |
| Clonidine | 23 | $3,640 |
| Dabigatran Etexilate Mesylate | 15 | $3,332 |
Prescribing Profile
43
Unique Drugs
$504K
Patient Profile
76
Avg Age
45%
Female
1.71
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About